Insiders ACADIA Pharmaceuticals Inc.

Equities

ACAD

US0042251084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
14.79 ^USD	-0.40%		-3.02%	-52.76%

May. 16	Transcript : ACADIA Pharmaceuticals Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM
May. 10	UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ACADIA Pharmaceuticals Inc. Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development	Apr. 02	CI
Acadia Pharmaceuticals Insider Sold Shares Worth $317,081, According to a Recent SEC Filing	Mar. 28	MT
Acadia Pharmaceuticals Inc. Announces Executive Changes	Jan. 31	CI
Acadia Pharmaceuticals Appoints Jennifer J. Rhodes Chief Legal Officer	Jan. 31	MT
Acadia Pharmaceuticals Inc. Announces Management Changes	Jan. 30	CI
Acadia Pharmaceuticals Insider Sold Shares Worth $115,645, According to a Recent SEC Filing	Nov. 22	MT
Acadia Pharmaceuticals Insider Sold Shares Worth $112,294, According to a Recent SEC Filing	Nov. 22	MT
Doug Williamson to Leave ACADIA Pharmaceuticals Inc. as Executive Vice President, Head of Research and Development	Nov. 21	CI
Acadia Pharmaceuticals Insider Sold Shares Worth $1,132,323, According to a Recent SEC Filing	23-10-09	MT
Acadia Pharmaceuticals Inc. Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications	23-09-19	CI
Acadia Pharmaceuticals Appoints Kevin Oliver Chief Business Officer	23-07-25	MT
Acadia Pharmaceuticals Inc. Appoints Kevin R. Oliver as Senior Vice President, Chief Business Officer and Member of Executive Management Committee	23-07-24	CI
Insider Sell: Acadia Pharmaceuticals	23-07-19	MT
Insider Sell: Acadia Pharmaceuticals	23-07-14	MT
Insider Sell: Acadia Pharmaceuticals	23-05-03	MT
Insider Sell: Acadia Pharmaceuticals	23-01-17	MT
ACADIA Pharmaceuticals Inc. Announces Executive Changes	23-01-09	CI
Acadia Pharmaceuticals Inc. Announces Retirement of Srdjan Stankovic as President	22-10-27	CI
Acadia Pharmaceuticals Inc Appoints Adora Ndu to Its Board of Directors	22-10-13	CI
ACADIA Pharmaceuticals Promotes Mark Schneyer to Chief Financial Officer	21-12-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders ACADIA Pharmaceuticals Inc.

Equities

ACAD

US0042251084

Insiders

Filters